Introduction
The prevalence of chronic obstructive pulmonary disease (COPD) is increasing, and it is expected to become the fourth cause of death worldwide by 2030 1 . To date, the molecular mechanisms leading to the development of COPD are poorly understood, and there are currently no effective therapies that can prevent the pathogenesis of COPD. Therefore, finding new biomarkers and understanding the biological mechanism of COPD are essential to reduce the disease morbidity and mortality.
COPD is characterized by airflow limitation that is not fully reversible and an abnormal inflammatory response in the lung. Previous studies demonstrated that environmental risk factors, including cigarette smoking, air pollution, and chemi-
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www.e-trd.org cals, contributed to the development of COPD [2] [3] [4] . Although cadmium (Cd) is a constituent of cigarette smoke, the precise role of Cd in COPD is not fully defined. However, growing evidence indicates that Cd may play a key role in smokinginduced disorders, including impaired lung function, chronic inflammation, or the development of emphysema [5] [6] [7] [8] . In our previous genetic association study on patients with COPD, we identified candidate disease susceptibility loci. Notably, a number of single nucleotide polymorphisms were identified in the ACN9 gene, of which the risk alleles of rs10231916 and rs10229181 were associated with attenuated expression of ACN9 in the lung 9 . These findings suggest that altered expression of ACN9 may contribute to human lung pathological conditions. Nevertheless, the biological function or the pathogenic roles of ACN9 have not been widely studied. The human ACN9 gene (sdh7 in yeast, SDHAF3 in humans) encompasses a 65,174 bp region at chromosome 7q22.1 (chr 7:97,116,593-97,181,763) and consists of two exons with protein-coding exons. It belongs to the LYR motif protein family, which is localized in the mitochondrial matrix and is related to Fe-S cluster protection in succinate dehydrogenase (SDH) maturation in yeast and Drosophila 10, 11 . In this study, we determined the functional roles of ACN9 by mRNA profiling after knocking down ACN9 expression. We also investigated whether ACN9 has a role in the inflammatory signaling pathway in airway epithelial cells.
Materials and Methods

Immunohistochemistry
Human lung tissue samples were provided from Biobank of the Kangwon National University Hospital (KNUH) in accordance with an approved protocol by Institutional Review Board of KNUH (2014-12-014). Human lungs and other tissues from the surgical specimens were fixed in 10% formalin solution at 60°C overnight and embedded in paraffin. After deparaffinization with graded concentrations of xylene and ethanol, slides were immersed in 3% H 2 O 2 in phosphatebuffered saline (PBS; Thermo Fisher Scientific Inc., Waltham, MA, USA) for 30 minutes at room temperature to block endogenous peroxidase activity. Then, they were incubated with 3% bovine serum albumin (BSA) for 2 hours to reduce nonspecific background staining. The sections were then incubated with monoclonal antibody against ACN9 (1:50, Abcam, Cambridge, UK) in PBS with BSA.
In situ hybridization
In situ hybridization was performed using formalin-fixed paraffin-embedded (FFPE) tissues using the RNAScope 2.0 RED assay, according to the manufacturer's instructions (#310036; Advanced Cell Diagnostics Inc., Hayward, CA, USA). First, 4-μm sections were cut from the FFPE blocks and mounted on Superfrost Plus microscope slides (Thermo Fisher Scientific Inc.). Slides were placed at 60°C for 1 hour in a dry oven. Mounted sections were deparaffinized in xylene, dehydrated in 100% ethanol, and then treated serially with ACD pretreatment 1 (endogenous hydrogen peroxidase block) for 10 minutes at room temperature, ACD pretreatment 2 (boiling in citrate buffer) for 8-12 minutes at 98°C-100°C, and ACD pretreatment 3 (protease digestion) for 12-30 minutes at 40°C. Pretreatment 2 and 3 conditions for each paraffin block were optimized to maximize the signal-to noise ratio using internal control (Hs-PPIB, #313901; Advanced Cell Diagnostics Inc.) and negative control (Fast Red, #310043; Advanced Cell Diagnostics Inc.) RNA probes. Next, hybridization between the target RNA and the selected ACD probe (Hs-SDHAF3, #441611; Advanced Cell Diagnostics Inc.) was performed during a 2-hour incubation period.
Cell culture
Unless otherwise indicated, all materials for cell culture were purchased from Gibco (Thermo Fisher Scientific Inc.). The human bronchial epithelial cell line (BEAS-2B) was kindly provided by Biomedical Research Institute at Seoul National University Hospital. BEAS-2B cells were maintained in defined keratinocyte serum-free medium containing epidermal growth factor, 100 U/mL of penicillin, and 100 μg/ mL of streptomycin. Cell cultures were incubated at 37°C in humidified atmosphere containing 5% CO 2 . BEAS-2B cells were transfected with human ACN9 siRNA (ACN9 ON-TAR-GET plus SMART pool) and/or negative control siRNA (ON-TARGET plus non-targeting pool) at a final concentration of 15 nM in the presence of DharmaFECT reagent (Dharmacon, Lafayette, CO, USA), as per the manufacturer' s protocol. After transfection, the cells were incubated with or without 10 μM Cd for 24 hours for quantitative polymerase chain reaction analysis and Western blotting 5 . Cd was dissolved in sterile water and stored as a stock solution. It was diluted in cell media to reach the indicated concentration. www.e-trd.org systems). Quantitation was normalized with 18s rRNA (internal control). Quantitative real time polymerase chain reaction was performed using primer sequences listed in Table 1 . For quality control, RNA purity and integrity were evaluated by OD 260/280 ratio and analyzed by Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA).
Enzyme-linked immunosorbent assay
To quantitate the secreted interleukin 6 (IL-6) levels, the cell culture supernatants of BEAS-2B cells were measured by human IL-6 Quantikine ELISA Kit (R&D Systems, Minneapolis, MN, USA). The enzyme-linked immunosorbent assay plates were read using a microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Western blot analysis
Cell lysates were separated on an sodium dodecyl sulfate polyacrylamide gel electrophoresis gel (10% or 15%), transferred onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA), and blocked with 3% skim milk. The membrane was probed with primary antibodies against antihuman interleukin 1β (IL-1β) antibody (AF-201-NA; R&D Systems), anti-IL-1 RA antibody (SC-25444; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-mitogen-activated protein kinase (MAPK) signal pathway sampler kit antibody (#9913; Cell Signaling Technologies, Danvers, MA, USA), and anti-β-actin antibody (SC-47778, Santa Cruz Biotechnology) overnight at 4°C. The membranes were further probed with horseradish peroxidase-conjugated secondary anti-sera (A9917, A6667, or A5420; Sigma) and visualized by PowerOpti ECL solution (Bionote, Hwaseong, Korea) and a cooled CCD camera system (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Whole transcript expression arrays
The Affymetrix Whole transcript Expression Array process was executed according to the manufacturer' s protocol (GeneChip Whole Transcript PLUS Reagent Kit; Affymetrix, Santa Clara, CA, USA). cDNA was synthesized using the GeneChip WT (whole transcript) Amplification Kit (Affymetrix) as described by the manufacturer. The sense cDNA was then fragmented and biotin-labeled with terminal deoxynucleotidyl transferase (TdT) using the GeneChip WT Terminal Labeling Kit (Affymetrix). Approximately 5.5 μg of labeled DNA target was hybridized to the Affymetrix GeneChip Human 2.0 ST Array at 45°C for 16 hours. Hybridized arrays were washed and stained on a GeneChip Fluidics Station 450 and scanned on a GCS3000 Scanner (Affymetrix). Signal values were computed using the Affymetrix GeneChip Command Console software.
Raw data preparation and statistical analysis
Raw data were extracted automatically in Affymetrix data extraction protocol using the software provided by Affymetrix GeneChip Command Console software. After importing CEL files, the data were summarized and normalized with robust multi-average (RMA) method implemented in Affymetrix Expression Console software. We exported the result with genelevel RMA analysis and performed the differentially expressed gene (DEG) analysis. Statistical significance of the expression data was determined using fold change. For a DEG set, hierarchical cluster analysis was performed using complete linkage and Euclidean distance as a measure of similarity. Geneenrichment and functional annotation analysis for significant probe list was performed using DAVID (http://david.abcc.ncifcrf.gov/home.jsp). All data analyses and visualization of DEGs were conducted using R 3.1.2 (http://www.r-project.org). Statistical analyses were performed with t test for multiple groups using GraphPad Prism (GraphPad Software, San Diego, CA, USA). p-value is indicated in the figure. 
ACN9 is expressed in lung tissues
We investigated cellular localization of ACN9 expression in human tissues using both in situ hybridization and immunohistochemistry. We observed positive staining for ACN9 within the bronchial epithelium and lymphoid-like cells in normal lung tissues ( Figure 1A) . We next assessed the protein expression of ACN9 in human tissues, including the liver and lung tissues ( Figure 1B ). Our expression patterns revealed a significant expression of ACN9 in human lung tissues.
The potential Cd and ACN9 are associated with immune response
To identify endogenous ACN9 target genes, we transiently transfected siACN9 into bronchial epithelial cells. To test the efficiency of the ACN9 transcript suppression, BEAS-2B cells were transfected with 15 nM siRNA and cultured for 24 hours. Then, the cells were processed for Western blot analysis to determine the expression of ACN9. As expected, transfection of BEAS-2B cells with 15 nM siRNA resulted in approximately 70% silencing of ACN9 gene expression levels compared with control ( Figure 2A ). Cd treatment further decreased ACN9 expression ( Figure 2B) . Microarray results identified genes that were significantly altered by ACN9 knock down with or without Cd (>2.0-fold, p<0.05) ( Figure 2C ). We identified 113 upregulated genes and 103 downregulated genes as a result of ACN9 knockdown in BEAS-2B. We also identified 408 upregulated genes and 251 downregulated genes in response to Cd treatment after ACN9 silencing ( Figure 2D ). We found that the GO categories of "defense response," "inflammatory response, " and "innate immune response" were significantly enriched with Cd treatment, while "cell surface receptor" and "sensory perception to chemical" were ranked at the top list in ACN9 silencing ( Figure 2E ).
Silencing ACN9 promotes inflammatory cytokine production in Cd-treated BEAS-2B cells
To investigate the role of ACN9 in the inflammatory responses of human bronchial epithelial cells, BESA-2B cells were treated with Cd after transfection with siACN9. Silencing ACN9 before the addition of Cd enhanced the inflammatory responses compared to that in Cd-treated control cells ( Figure  3A, B) . These results showed that silencing ACN9 significantly promoted the Cd-induced proinflammatory cytokine production in BEAS-2B cells. We next determined whether ACN9 silencing has an effect on Cd-induced MAPK activity. After silencing ACN9, JNK, and p38/MAPK pathway was further activated by Cd treatment in BEAS-2B cells, while ERK activation was not influenced by ACN9 silencing (Figure 3C, D) .
Discussion
In this study, ACN9 gene and proteins were found in normal lung epithelial cells and lymphoid-like cells. Gene expres- The protein expression levels of phosphorylated JNK, ERK, and p38 MAPK were calculated by normalized to total ERK, and IL-1β and IL-1RA were normalized by β-actin. For enzyme-linked immunosorbent assay and quantitative real time polymerase chain reaction, statistical evaluation was conducted, using Student' s t test *p≤0.05, **p≤0.01, and ***p≤0.001 were considered significant. Data shown is representative of at least three independent experiments. TNF-α: tumor necrosis factor α; COX2: cyclooxygenase 2; iNOS: inducible nitric oxide synthase; MMP9: matrix metalloproteinase 9; siNC: small interference RNA of non-targeting control. www.e-trd.org other LYR motif proteins are linked to diseases such as insulin resistance, muscular hypotonia, deficiency of multiple mitochondrial oxidative phosphorylation complex, and alcohol dependence [12] [13] [14] [15] . ACN9 is a central component in the ancient Fe-S cluster metabolism and in protecting SDHB from oxidative stress during the assembly process in Drosophila 16 . High concentrations of reactive oxygen species (ROS) damage Fe-S cluster, and protection of the sensitive Fe-S clusters is important in the presence of oxidative stress. Respiratory chain complexes I, II, and III play a role in producing a significant amount of ROS in mitochondria. Deletion of ACN9 caused a dramatic SDH deficiency with muscular and neuronal defects that are suggestive of neurodegeneration observed in humans with mutations in SDHAF1 10, 11, 17 . Until now, only a few studies have investigated the effects of ACN9 on inflammatory response and mitochondrial dysfunction 18 , and no studies have been performed in human lung epithelial cells. In the present study, we used in situ hybridization and immunohistochemistry to investigate the cellular localization of ACN9 mRNA and protein in human lung tissues. Our results indicate that ACN9 expression was detected in both airway epithelium and lymphoid cells in the lung tissues.
The airway epithelium is the barrier between inhaled air containing toxic compounds, including Cd, and the underlying lung tissue. To maintain this barrier, continuous cell replacement and repair of the epithelium are of crucial importance, while noxious agents are most important risk factor for airway diseases. In general, Cd exposure causes accumulation in humans at low concentrations over long period. Therefore, we selected 10 μM of Cd dose in bronchial epithelial cells as in vitro model for airway exposure to the noxious agent. The final consequence of the Cd-induced electron transport chain blockade is the loss of capacity of the mitochondria to generate ATP. Exposure to Cd results in the increased formation of reducing equivalents (NADH) by the citric acid cycle and increased mitochondrial oxygen consumption and ATP formation via oxidative phosphorylation 19 . This could be due to the direct action of Cd on mitochondrial function, which mediates the inhibition of electron transfer, disruption of the respiratory complexes, and membrane permeability. Recent studies have suggested that an abnormality in mitochondrial function is associated with development of lung diseases [20] [21] [22] . The large amount of free radicals present in inhaled Cd will initially be able to induce an apoptotic signal in the exposed cells 23 . We investigated the genomic response to Cd exposure in bronchial epithelial cells after ACN9 silencing using microarray to understand the molecular mechanism of ACN9 24 . In our study, several genes were notably upregulated or downregulated in ACN9 knockdown cells with or without Cd stress as compared to that in control cells. Cd stress was associated with inflammatory responses, while ACN9 silencing in bronchial epithelial cells was associated with pathways such as sensory perception to chemical and cell surface receptorlinked signal transduction. We further tested the roles of ACN9 in the intracellular mechanism of exposure to Cd in terms of proinflammatory cytokines in bronchial epithelial cells (BEAS-2B). We observed that ACN9 silencing significantly increased the expression of proinflammatory cytokines at mRNA and translational levels when BEAS-2B cells were treated with Cd after ACN9 silencing. Furthermore, ACN9 silencing led to further activation of the p38/MAPK pathway induced by Cd-treated cells.
Because ACN9 is related to SDH, a possible mechanism of the inflammatory response induced by ACN9 silencing is via SDH that is involved in the inflammatory response 25 . Previous reports have shown that SDH mutations display elevated levels of succinate in immune cells. Succinate stabilizes hypoxiainducible factor-1α (HIF-1α) by inhibiting prolyl hydroxylase domain enzyme activity. Stabilized HIF1-α binds to HIF response elements in target genes, including those encoding glycolytic enzymes, angiogenic factors, and the inflammatory cytokine IL-1β, thereby exacerbating inflammation 26 . We speculated that ACN9 silencing diminished the consumption of oxygen and production of ATP. High succinate concentrations have been detected in the plasma of patients. In addition, patients harboring mutations in SDH exhibited increased HIF-1α activity [27] [28] [29] . Further study is needed to investigate the mechanisms by which succinate enhances proinflammatory cytokine production in BEAS-2B cells.
There are some limitations related to our study. First, we measured several inflammatory cytokines at gene levels by real-time polymerase chain reaction. Although we measured IL-6 in the supernatant, other protein-level inflammatory reactions were not measured. Second, we studied bronchial cell models, but several cell types may be involved in the pathogenesis of COPD. Further in vivo model should be studied to further understand the role of ACN9 gene.
In conclusion, our study provides new insight into the function of ACN9 in the pathogenesis of COPD. Further study is needed to understand the role of ACN9 in the inflammatory response and mitochondrial dysfunction of airway diseases.
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